Price target
222.640.000.00%
The 14 analysts offering 1 year price forecasts for 56S1 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 14 analysts giving stock ratings to 56S1 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
56S1 EPS for the last quarter is 0.76 EUR despite the estimation of 0.80 EUR. In the next quarter EPS is expected to reach 0.97 EUR. Track more of SARTORIUS STEDIM BIOTECH financials and stay on top of what is up with the company.
In the next quarter SARTORIUS STEDIM BIOTECH revenue is expected to reach 710.61 M EUR. Check out SARTORIUS STEDIM BIOTECH revenue and earnings and make informed decisions.
According to analysts, 56S1 price target is 222.64 EUR with a max estimate of 310.00 EUR and a min estimate of 134.00 EUR. Check if this forecast comes true in a year, meanwhile watch SARTORIUS STEDIM BIOTECH stock price chart and keep track of the current situation with 56S1 news and stock market news.
We've gathered opinions of 14 analysts rating 56S1 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.